---
annotations:
- type: Pathway Ontology
  value: '"cell cycle pathway'
- type: Pathway Ontology
  value: M/G1 transition pathway
authors:
- MaintBot
- MartijnVanIersel
- ReactomeTeam
- Anwesha
- DeSl
description: Mitotic G1-G1/S phase involves G1 phase of the mitotic interphase and
  G1/S transition, when a cell commits to DNA replication and divison genetic and
  cellular material to two daughter cells.<p>During early G1, cells can enter a quiescent
  G0 state. In quiescent cells, the evolutionarily conserved DREAM complex, consisting
  of the pocket protein family member p130 (RBL2), bound to E2F4 or E2F5, and the
  MuvB complex, represses transcription of cell cycle genes (reviewed by Sadasivam
  and DeCaprio 2013).<p>During early G1 phase in actively cycling cells, transcription
  of cell cycle genes is repressed by another pocket protein family member, p107 (RBL1),
  which forms a complex with E2F4 (Ferreira et al. 1998, Cobrinik 2005). RB1 tumor
  suppressor, the product of the retinoblastoma susceptibility gene, is the third
  member of the pocket protein family. RB1 binds to E2F transcription factors E2F1,
  E2F2 and E2F3 and inhibits their transcriptional activity, resulting in prevention
  of G1/S transition (Chellappan et al. 1991, Bagchi et al. 1991, Chittenden et al.
  1991, Lees et al. 1993, Hiebert 1993, Wu et al. 2001). Once RB1 is phosphorylated
  on serine residue S795 by Cyclin D:CDK4/6 complexes, it can no longer associate
  with and inhibit E2F1-3. Thus, CDK4/6-mediated phosphorylation of RB1 leads to transcriptional
  activation of E2F1-3 target genes needed for the S phase of the cell cycle (Connell-Crowley
  et al. 1997). CDK2, in complex with cyclin E, contributes to RB1 inactivation and
  also activates proteins needed for the initiation of DNA replication (Zhang 2007).
  Expression of D type cyclins is regulated by extracellular mitogens (Cheng et al.
  1998, Depoortere et al. 1998). Catalytic activities of CDK4/6 and CDK2 are controlled
  by CDK inhibitors of the INK4 family (Serrano et al. 1993, Hannon and Beach 1994,
  Guan et al. 1994, Guan et al. 1996, Parry et al. 1995) and the Cip/Kip family, respectively.  View
  original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=453279 Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1858
- /instance/WP1858
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1858.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Mitotic G1-G1/S phase involves G1 phase of the mitotic interphase and
    G1/S transition, when a cell commits to DNA replication and divison genetic and
    cellular material to two daughter cells.<p>During early G1, cells can enter a
    quiescent G0 state. In quiescent cells, the evolutionarily conserved DREAM complex,
    consisting of the pocket protein family member p130 (RBL2), bound to E2F4 or E2F5,
    and the MuvB complex, represses transcription of cell cycle genes (reviewed by
    Sadasivam and DeCaprio 2013).<p>During early G1 phase in actively cycling cells,
    transcription of cell cycle genes is repressed by another pocket protein family
    member, p107 (RBL1), which forms a complex with E2F4 (Ferreira et al. 1998, Cobrinik
    2005). RB1 tumor suppressor, the product of the retinoblastoma susceptibility
    gene, is the third member of the pocket protein family. RB1 binds to E2F transcription
    factors E2F1, E2F2 and E2F3 and inhibits their transcriptional activity, resulting
    in prevention of G1/S transition (Chellappan et al. 1991, Bagchi et al. 1991,
    Chittenden et al. 1991, Lees et al. 1993, Hiebert 1993, Wu et al. 2001). Once
    RB1 is phosphorylated on serine residue S795 by Cyclin D:CDK4/6 complexes, it
    can no longer associate with and inhibit E2F1-3. Thus, CDK4/6-mediated phosphorylation
    of RB1 leads to transcriptional activation of E2F1-3 target genes needed for the
    S phase of the cell cycle (Connell-Crowley et al. 1997). CDK2, in complex with
    cyclin E, contributes to RB1 inactivation and also activates proteins needed for
    the initiation of DNA replication (Zhang 2007). Expression of D type cyclins is
    regulated by extracellular mitogens (Cheng et al. 1998, Depoortere et al. 1998).
    Catalytic activities of CDK4/6 and CDK2 are controlled by CDK inhibitors of the
    INK4 family (Serrano et al. 1993, Hannon and Beach 1994, Guan et al. 1994, Guan
    et al. 1996, Parry et al. 1995) and the Cip/Kip family, respectively.  View original
    pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=453279 Reactome].
  keywords:
  - RBL1
  - 'CDK1 gene '
  - duplex
  - CDKN1A,CDKN1B,(CDKN1C)
  - 'RPA4 '
  - RB1
  - 'SHFM1 '
  - 'PSMB4 '
  - ATP
  - HDAC1:RBL2:E2F4,E2F5:TFDP1,TFDP2; HDAC1:RBL1:E2F4:TFDP1,TFDP2
  - CDKN1A,CDKN1B
  - 'ORC1 gene '
  - 'MCM2 '
  - B:CDK1:ORC:origin
  - 'POLE3 '
  - TOP2A
  - 'p-S28-LIN52 '
  - 'MCM8 '
  - E2F1:TFDP1,TFDP2:DHFR gene
  - RBL1:Cyclin E/A:CDK2
  - Oncogene Induced
  - CDK4/6:CCND:p-Y77-CDKN1A,p-Y88-CDKN1B,(p-Y91-CDKN1C)
  - CABLES1
  - 'p-Y77-CDKN1A '
  - 'POLE2 '
  - DREAM complex:PCNA
  - 'PSMB9 '
  - p-T401,S672,1035-RBL2:SCF(Skp2):Cks1
  - CCNE
  - 'p-S780-RB1 '
  - 'p-CDK2 '
  - 'RPS27A(1-76) '
  - FBXO5
  - signaling
  - E/A:CDK2:p-S130-CDKN1A,p-T187-CDKN1B:CUL1:SKP1:SKP2:CKS1B
  - 'MCM6 '
  - 'UBC(381-456) '
  - RNA primer-DNA
  - DYRK1A
  - CCNA2 gene
  - 'PSMB7 '
  - 'p-S807-RB1 '
  - CDKN1B:(CDK4:CCND1,(CDK2:CCNE1))
  - E2F1:TFDP1,TFDP2:CDK1 gene
  - TYMS gene
  - 'PSMF1 '
  - GMNN
  - MYC:MAX
  - 'CDK6 '
  - TK1
  - 'E2F1 '
  - 'p-Y419-SRC '
  - CCNE:CDK2
  - 'SKP1 '
  - 'PPP2R2A '
  - E2F1 gene
  - Pi
  - DREAM complex:CDC6
  - 'UBC(1-76) '
  - E2F1:TFDP1,TFDP2:CCNE1 gene
  - PIP3 activates AKT
  - damage
  - 'CCNE1 gene '
  - p-T,p-S-AKT
  - INK4
  - HDAC1:RBL2:E2F4,E2F5:TFDP1,TFDP2; HDAC1:RBL1:E2F4:TFDP1,TFDP2:MYBL2 gene
  - H2O
  - replication
  - 'PSMD6 '
  - 'FBXO5 gene '
  - 'PSMD11 '
  - pre-replicative
  - HDAC1:RBL2:E2F4,E2F5:TFDP1,TFDP2
  - 'LIN52 '
  - 'DBF4 '
  - 'RPA3 '
  - 'PSME2 '
  - CCNA1 gene
  - POLA1
  - RBL2
  - 'Pi '
  - 'PSMD14 '
  - 'TK1 gene '
  - CCNA1
  - ORC:origin of
  - 'Cyclin E '
  - 'PSMD4 '
  - 'p-S811-RB1 '
  - p-Y342-PTK6
  - 'E2F5 '
  - 'CCNA2 '
  - 'p-Y91-CDKN1C '
  - 'MNAT1 '
  - CKS1B
  - HDAC1:RBL2:E2F4,E2F5:TFDP1,TFDP2; HDAC1:RBL1:E2F4:TFDP1,TFDP2:CDK1 gene
  - 'RRM2 gene '
  - SMAD2/SMAD3:SMAD4
  - E2F1:TFDP1,TFDP2:CDT1 gene
  - CDC6 gene
  - 'RBL1 '
  - CCNE1 gene
  - 'PSMC6 '
  - CDC6
  - TYMS
  - 'CDKN2C '
  - RBL1 gene
  - 'CCNA1 gene '
  - 'TOP2A gene '
  - POLA1 gene
  - 'ORC3 '
  - p-Y88-CDKN1B:(CDK4:CCND1,(CDK2:CCNE1))
  - 'RPA2 '
  - MCM10
  - DNA polymerase
  - complex
  - E2F1:TFDP1,TFDP2:FBXO5 gene
  - CDK1 gene
  - E2F1:TFDP1,TFDP2:RRM2 gene
  - 'p16INK4A '
  - Cyclin E:p-CDK2
  - 'PSMB10 '
  - RBL1:E2F4:DP1/2:Cyclin E/A:CDK2
  - 'RB1 '
  - 'PSMD10 '
  - RPA1-4
  - CDK4,CDK6:CCND:CDKN1A,CDKN1B,(CDKN1C)
  - 'PSMB1 '
  - 'p-T145-CDKN1A '
  - 'CDKN2B '
  - 'PRIM2 '
  - 'PSMA1 '
  - 'ORC2 '
  - 'PSMD9 '
  - 'PSMA6 '
  - 'UBB(77-152) '
  - Senescence
  - 'PSMC5 '
  - 'CDK4 '
  - 'CUL1 '
  - 'SKP2 '
  - 'UBC(77-152) '
  - 'PSMA3 '
  - CCNE1
  - 'PRIM1 '
  - 'CDKN1C '
  - DDK
  - 'UBC(609-684) '
  - DHFR
  - Transcriptional
  - 'p-Y88-CDKN1B '
  - CUL1:SKP1:SKP2
  - 'p-Y397-LYN '
  - 'TFDP2 '
  - 'CCND2 '
  - 'p-T187-CDKN1B '
  - CDK1
  - gene
  - CDC25A
  - PCNA gene
  - 'CDKN1B '
  - E2F1:TFDP1,TFDP2:PCNA gene
  - 'p-T157-CDKN1B '
  - CDC25A gene
  - 'CKS1B '
  - Aborted replication
  - p-T-CDKN1A/B
  - 'p-T356-RB1 '
  - CCNE:p-T160-CDK2:hypophosphorylated RB1
  - 'PSME3 '
  - p-MCM2-7
  - 'PPP2R1B '
  - E2F4:TFDP1,TFDP2
  - 'p-S252-RB1 '
  - FBXO5 gene
  - Ub-p-T401,S672,1035-RBL2
  - E2F4,E2F5:TFDP1,TFDP2
  - 'LIN9 '
  - 'ORC6 '
  - 'CCNB1 '
  - 'POLA1 '
  - CDKN1B
  - CDT1
  - 'PPP2CB '
  - Ub
  - 'MCM5 '
  - RBL1:E2F4:TFDP1,TFDP2
  - 'RB1:E2F1,E2F2,E2F3:TFDP1,TFDP2:'
  - CAK
  - 'RNA primer:origin duplex with DNA damage '
  - 'CDC45 gene '
  - E2F1:TFDP1,TFDP2
  - MYC:MAX:CDC25A gene
  - 'PCNA gene '
  - CDK2
  - MYBL2
  - 'RBL1 gene '
  - 'CDK7 '
  - 'p-S608-RB1 '
  - CDK4,CDK6:CCND
  - E2F1:TFDP1,TFDP2:CCNA1 gene
  - 'DNA primer '
  - hyperphosphorylated
  - 'p-12Y-JAK2 '
  - 'PSMD12 '
  - 'p-T160-CDK2 '
  - 'LIN54 '
  - 'CDT1 '
  - 'CDT1 gene '
  - DREAM complex
  - p-Y342-PTK6:CDKN1B:(CDK4:CCND1,(CDK2:CCNE1))
  - primer:origin
  - 'CDKN2D '
  - 'p-T305,S472-AKT3 '
  - 'PPP2R3B '
  - 'MYBL2 gene '
  - alpha:primase
  - 'CCNE2 '
  - 'PSMB8 '
  - 'ORC4 '
  - 'PSMA4 '
  - 'CCNA '
  - PCNA
  - E/A:p-T160-CDK2:CDKN1A,CDKN1B
  - 'p-T177-CDK6 '
  - 'PSMC3 '
  - 'PSMC2 '
  - MCM10:pre-replicative complex
  - alpha:primase:DNA
  - 'E2F1 gene '
  - 'p-T826-RB1 '
  - 'GMNN '
  - 'p-T308,S473-AKT1 '
  - 'MCM7 '
  - E2F1:TFDP1,TFDP2:ORC1 gene
  - 'PSMD2 '
  - 'UBC(153-228) '
  - Cyclin D
  - 'cyclin '
  - 'CDC25A gene '
  - 'PSMB2 '
  - Signaling by PTK6
  - CDC45 gene
  - DHFR gene
  - 'MYC '
  - 'CDK1 '
  - 26S proteasome
  - E/A:CDK2:p-S130-CDKN1A,p-T187-CDKN1B:CUL1:SKP1:SKP2:CKS1B:3xubiquitin
  - 'CCNE1 '
  - 'p-S612-RB1 '
  - 'CDC7 '
  - polymerase
  - 'p-T401,S672,S1035-RBL2 '
  - 'PPP2CA '
  - MuvB complex
  - E2F6:(TFDP1,TFDP2):RRM2 gene
  - RRM2
  - 'CCNA1 '
  - 'POLE4 '
  - E2F1:TFDP1,TFDP2:CDC45 gene
  - E2F1:TFDP1,TFDP2:CDC6 gene
  - DREAM complex:CDC25A
  - MCM2-7
  - Cyclin E:p-T160-CDK2
  - 'E2F2 '
  - 'E2F6 '
  - 'UBB(1-76) '
  - TOP2A gene
  - 'MAX '
  - 'ORC1 '
  - 'UBC(229-304) '
  - 'E2F3 '
  - HDAC1:RBL2:E2F4,E2F5:TFDP1,TFDP2; HDAC1:RBL1:E2F4:TFDP1,TFDP2:E2F1 gene
  - CDK4,CDK6:INK4
  - 'RBL2 '
  - 'PSMB5 '
  - E2F1,E2F2,E2F3:TFDP1,TFDP2
  - of replication
  - 'POLE '
  - duplex with DNA
  - 'PSMD8 '
  - RBL2:Cyclin E/A:CDK2
  - CDKN1A
  - CDK4,CDK6
  - 'TFDP1 '
  - Cyclin B:CDK1
  - 'p-S130-CDKN1A '
  - ORC1
  - 'CCNA2 gene '
  - DREAM complex:RBL1
  - MCM10:active
  - RB1:RNA primer-DNA
  - 'p-S795-RB1 '
  - 'UBC(457-532) '
  - DREAM complex:TOP2A
  - 'origin of replication '
  - 'POLA2 '
  - E2F1:TFDP1,TFDP2:CDC25A gene
  - 'E2F4 '
  - 'PSMD5 '
  - 'PSME1 '
  - 'p-T309,S474-AKT2 '
  - 'PSMA5 '
  - Cdt1:geminin
  - CDC45
  - 'p-T373-RB1 '
  - complex:CDC45:RPA1-4
  - Oxidative Stress
  - CCNA2
  - Cyclin
  - CDK:DDK:MCM10:active
  - p-T369,S640,S964,S975-RBL1
  - monophosphorylated
  - 'POLA1 gene '
  - ORC1 gene
  - 'p-S788-RB1 '
  - epsilon:origin
  - 'p-T172-CDK4 '
  - HDAC1
  - E:CDK2:CDKN1A,CDKN1B
  - epsilon
  - PP2A
  - 'CCND1 '
  - Senescence-Associated Secretory Phenotype (SASP)
  - CCNA:p-T160-CDK2,CCNE:p-T160-CDK2
  - ADP
  - 'PSMB3 '
  - 'CDC6 '
  - 'UBB(153-228) '
  - RRM2 gene
  - alpha:origin
  - CDT1 gene
  - E2F1:TFDP1,TFDP2:TK1
  - p-T172-CDK4,p-T177-CDK6:CCND:CDKN1A,CDKN1B,(CDKN1C); p-T172-CDK4,p-T177-CDK6:CCND;
    (p-T172-CDK4,p-T177-CDK6:CCND:p-Y88-CDKN1B)
  - p-MuvB complex
  - p-T401,S672,S1035-RBL2
  - activity of
  - origin of
  - 'PSMC4 '
  - CDK4,CDK6:CCND:CDKN1A,CDKN1B,(CDKN1C); CDK4,CDK6:CCND; (CDK4,CDK6:CCND:p-Y88-CDKN1B)
  - 'PSMD13 '
  - 'DHFR gene '
  - WEE1
  - 'CDC6 gene '
  - 'PSMB6 '
  - 'PSMD7 '
  - 'PSMA7 '
  - 'HDAC1 '
  - HDAC1:RBL2:E2F4,E2F5:TFDP1,TFDP2; HDAC1:RBL1:E2F4:TFDP1,TFDP2:CCNA2 gene
  - RBL2:E2F4/5:DP1/2:Cyclin E/A:CDK2
  - MYBL2 gene
  - heterotrimer
  - 'p-Y342-PTK6 '
  - 'UBC(305-380) '
  - 'PSMC1 '
  - complex:CDC45
  - 'CCNH '
  - 'MCM10 '
  - 'PSMD1 '
  - 'p-S230-RB1 '
  - 'CCND3 '
  - RBL2:E2F4,E2F5:TFDP1,TFDP2
  - 'RNA primer '
  - 'UBC(533-608) '
  - (p-Y342-PTK6,p-Y397-LYN,p-Y226,Y393-ABL1,p-Y419-SRC,p-5Y-JAK2)
  - TK1 gene
  - 'RPA1 '
  - 'PPP2R1A '
  - 'UBA52(1-76) '
  - 'RBBP4 '
  - 'p-Y226,Y393-ABL1 '
  - 'p-S249-RB1 '
  - 'CDKN1A '
  - 'ORC5 '
  - 'CDK2 '
  - 'PSMD3 '
  - 'LIN37 '
  - 'MCM3 '
  - E/A:p-T160-CDK2:p-S130-CDKN1A,p-T187-CDKN1B
  - 'MCM4 '
  - DREAM complex:E2F1
  - E2F1
  - 'PSMA2 '
  - 'CDC45 '
  - Induced Senescence
  - CUL1:SKP1:SKP2:CKS1B
  - Cyclin E/A:CDK2
  - E2F1:TFDP1,TFDP2:POLA1 gene
  - CDK
  - HDAC1:RBL1:E2F4:TFDP1,TFDP2
  - 'p-T821-RB1 '
  license: CC0
  name: Mitotic G1 phase and G1/S transition
seo: CreativeWork
title: Mitotic G1 phase and G1/S transition
wpid: WP1858
---